ZBP-89 promotes growth arrest through stabilization of p53

Molecular and Cellular Biology

Volumn 21, Issue 14, 2001, Pages 4670-4683

  Bai, L ^a   Merchant, J L ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HISTONE ACETYLTRANSFERASE; PROTEIN MDM2; PROTEIN P21; PROTEIN P53; PROTEIN ZBP 89; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL GROWTH; CELL LEVEL; CELL LINE; CELL PROLIFERATION; COMPLEX FORMATION; CONTROLLED STUDY; DNA BINDING; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY;

ANIMALS; APOPTOSIS; CELL DIVISION; CELL LINE; CELL NUCLEUS; DNA-BINDING PROTEINS; HUMANS; MICE; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; ZINC FINGERS;

ANIMALIA;

EID: 0034960978     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.21.14.4670-4683.2001     Document Type: Article

References (57)

1. Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha
2. Regulation of p53 function and stability by phosphorylation
3. Regulation of p53 stability
4. Recruitment of p300/CBP in p53-dependent signal pathways
5. Transcription factor ZBP-89 cooperates with histone acetyltransferase p300 during butyrate activation of p21waf1 transcription in human cells
6. Loss of function and p53 protein stabilization
7. p53 from complexity to simplicity: Mutant p53 stabilization, gain-of-function, and dominant-negative effect
8. The p53 pathway and apoptosis
9. Retinoic acid (RA) receptor transcriptional activation correlates with inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced ornithine decarboxylase (ODC) activity by retinoids: A potential role for trans-RA-induced ZBP-89 in ODC inhibition
10. E1A signaling to p53 involves the p19(ARF) tumor suppressor
11. Mammalian caspases: Structure, activation, substrates, and functions during apoptosis
12. WAF1, a potential mediator of p53 tumor suppression
13. Overexpression of p53 mRNA in colorectal cancer and its relationship to p53 gene mutation
14. BRCA1 as a potential human prostate tumor suppressor: Modulation of proliferation, damage responses and expression of cell regulatory proteins
15. The complexity of p53 modulation: Emerging patterns from divergent signals
16. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal
17. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of GI cyclin-dependent kinases
18. Cloning and characterization of a transcription factor that binds to the proximal promoters of the two mouse type I collagen genes
19. WAF promoter
20. Mdm2 promotes the rapid degradation of p53
21. p53 mutations in human cancers
22. Two domains of p53 interact with the TATA-binding protein, and the adenovirus 13S E1A protein disrupts the association, relieving p53-mediated transcriptional repression
23. RB regulates the stability and the apoptotic function of p53 via MDM2
24. Small peptides activate the latent sequence-specific DNA binding function of p53
25. p300/CBP-dependent and -independent transcriptional interference between NF-kappaB RelA and p53
26. Identification of p53 as a sequence-specific DNA-binding protein
27. p53: Puzzle and paradigm
28. Regulation of p53 stability by Mdm2
29. Regulation of Mdm2-directed degradation by the C terminus of p53
30. Transcription factor ZBP-89 regulates the activity of the ornithine decarboxylase promoter
31. p53, the cellular gatekeeper for growth and division
32. Binding and modulation of p53 by p300/CBP coactivators
33. p53 status and the efficacy of cancer therapy in vivo
34. ZBP-89, a Krüppel-type zinc finger protein, inhibits EGF induction of the gastrin promoter
35. Multiple lysine mutations in the C-terminal domain of p53 interfere with MDM2-dependent protein degradation and ubiquitination
36. p19ARF links the tumour suppressor p53 to Ras
37. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53
38. The p53 pathway
39. ZBP-89, a Kruppel-type zinc finger protein, inhibits cell proliferation
40. p53 mutations in colorectal cancer
41. Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation
42. Mutant p53: Gain-of-function oncoproteins and wild-type p53 inactivators
43. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
44. c-Abl neutralizes the inhibitory effect of Mdm2 on p53
45. BRCA1 signals ARF-dependent stabilization and coactivation of p53
46. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2
47. Overexpression of ZBP-89, a zinc finger DNA binding protein, in gastric cancer
48. P 19(ARF) stabilizes p53 by blocking nucleocytoplasmic shuttling of Mdm2
49. Surfing the p53 network
50. p53: Death star
51. The ins and outs of p53
52. 1 cyclin-dependent kinases
53. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A
54. A comparison of the biological activities of wild-type and mutant p53
55. The gadd and MyD genes define a novel set of mammalian genes encoding acidic proteins that synergistically suppress cell growth
56. BRCA1 physically associates with p53 and stimulates its transcriptional activity
57. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization